NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 25, 2025 — Skin, Bones, Hearts & Private Parts is hosting a CME conference in Nashville, TN from August 25-28, 2025. Earn up to 26 CME credits and 7.50 APRN Pharmacology credits. Expert speakers to cover Dermatology, Diabetes, Orthopedics, Women's Health, Cardiology, and Emergency Medicine.
May 24, 2025 — CD BioSciences launches customizable aging mouse models for drug development, providing valuable tools for researchers in the aging research sector. With precision-driven customization and accelerated drug development timelines, CD BioSciences offers a strategic edge for pharmaceutical companies in aging-related drug discovery.
May 23, 2025 — Ethema Health Corporation releases annual report with revenue growth and new facility expansions in Florida and Kentucky. The update showcases the company's commitment to quality patient care and strategic growth initiatives in the behavioral healthcare sector.
May 23, 2025 — Beam Therapeutics announces presentation of BEAM-101 trial data at EHA Congress 2025, highlighting the therapy's potential to provide a durable treatment for sickle cell disease. The focus on precision genetic medicines through base editing could revolutionize treatment approaches for genetic disorders.
May 23, 2025 — Beam Therapeutics announces presentation of BEAM-101 trial data at EHA 2025 Congress, showcasing potential breakthrough treatment for sickle cell disease.
May 23, 2025 — Soligenix introduces SGX943, a novel therapy to combat antibiotic-resistant bacteria. Learn more about the innovative solution to the public health threat posed by antibiotic misuse.
May 23, 2025 — Intelligent Bio Solutions is on track for a 2025 U.S. launch of its non-invasive drug screening system with high accuracy in detecting opiates through fingerprint sweat. Learn more about the company's innovative technology and the potential impact on various industries.
May 23, 2025 — Creative Biolabs leads in CAR-T therapy development, offering end-to-end solutions for plasmids, CAR viral vectors, and CAR cells. With increasing market demand, the company is crucial in accelerating research projects and bringing new therapies to patients in need.
May 22, 2025 — Soligenix leads in innovative therapies for rare diseases like CTCL with its treatment HyBryte(TM) and vaccine development programs for diseases like COVID-19 and Ebola. Learn more about the company's groundbreaking work and potential impact on rare disease treatment.
May 22, 2025 — Calidi Biotherapeutics announces breakthrough in cancer treatment delivery with promising preclinical results for RTNova platform. The innovative technology targets cancer cells while minimizing harm to healthy tissues, potentially improving treatment outcomes and survival rates.
May 22, 2025 — Nutriband CEO reports progress on Aversa Fentanyl patch with abuse deterrent properties in partnership with Kindeva Drug Delivery. A significant step towards commercialization and potential impact on opioid abuse and pain management.
May 22, 2025 — New brain tumor test revolutionizes cancer diagnosis by reducing time to hours. Early detection key for better treatment outcomes. Impactful breakthrough in cancer care.
May 22, 2025 — Learn how the American Heart Association's Get With The Guidelines program is transforming heart failure care, leading to improved patient outcomes and reduced mortality rates. Discover the impact of evidence-based practices and data-driven benchmarking in enhancing the quality of care for heart failure patients.
May 22, 2025 — NanoViricides President Dr. Anil Diwan praises FDA's COVID-19 booster shot policy, emphasizes need for alternatives like antiviral NV-387. Learn more about NanoViricides' nanomaterials for antiviral therapy.
May 22, 2025 — Tonix Pharmaceuticals CEO, Seth Lederman, discusses company updates and product pipeline at A.G.P.'s Annual Healthcare Company Showcase. Learn more about Tonix's innovative approach to pain management therapies and public health solutions.
May 22, 2025 — Purpose Healing Center in Scottsdale, Arizona, is now accepting AHCCCS plans for addiction and mental health treatment. This expansion of access to care demonstrates the center's commitment to providing high-quality treatment to more residents in need.
May 22, 2025 — Discover the revolutionary anti-aging formula, Prime Spermidine, by Bone Science. Harnessing the power of plant-based spermidine, this product offers high purity and superior bioavailability for optimal cellular renewal and vitality.
May 22, 2025 — Creative Biolabs announces enhancements to their Extracellular Vesicle platform, focusing on exosome isolation, characterization, and RNA sequencing. The upgrades cater to the demand in cancer, neurodegenerative, and autoimmune disease research, offering accurate data for early disease diagnostics and potential therapeutic developments.
May 21, 2025 — Dr. Barry Quart joins Connect Biopharma to advance rademikibart, a novel treatment for asthma and COPD, showcasing rapid action and safety in clinical trials.
May 21, 2025 — Telomir Pharmaceuticals receives $3 million investment from The Bayshore Trust, advancing key drug candidates Telomir-1 and Telomir-Ag2. CEO Erez Aminov emphasizes shareholder-friendly financing. IND submission for Telomir-1 planned by year-end. Visit the press release for more details.